Lilly Immergluck to Staphylococcus aureus
This is a "connection" page, showing publications Lilly Immergluck has written about Staphylococcus aureus.
Connection Strength
0.709
-
Immergluck LC. Community-associated infections in children--update on community-associated methicillin-resistant Staphylococcus aureus for the practitioner. Ethn Dis. 2007; 17(2 Suppl 2):S2-46-9.
Score: 0.280
-
Immergluck LC, Geng R, Li C, Edelson M, Lin X, Waller LA, Rust G, Xu J, Leong T, Baltrus P. Space-time trends of community-onset Staphylococcus aureus infections in children: a group-based trajectory modeling approach. Ann Epidemiol. 2023 06; 82:45-53.e1.
Score: 0.215
-
Immergluck LC, Jain S, Ray SM, Mayberry R, Satola S, Parker TC, Yuan K, Mohammed A, Jerris RC. Risk of Skin and Soft Tissue Infections among Children Found to be Staphylococcus aureus MRSA USA300 Carriers. West J Emerg Med. 2017 Feb; 18(2):201-212.
Score: 0.140
-
Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998 Feb 25; 279(8):593-8.
Score: 0.038
-
Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. N Engl J Med. 2017 06 29; 376(26):2545-2555.
Score: 0.036